{
    "organizations": [],
    "uuid": "4b4d53f650a186333a9ef897b80bb594b23b8fb3",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-hangzhou-tianmushan-pharmaceutical/brief-hangzhou-tianmushan-pharmaceutical-enterprise-receives-gmp-certificate-idUSL4N1Q33FS",
    "ord_in_thread": 0,
    "title": "Hangzhou Tianmushan Pharmaceutical Enterprise receives GMP certificate",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 13 (Reuters) - Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd :\n* Says it received goods manufacture practice (GMP) certificate from Zhejiang Food and Drug Administration\n* Certificate issued eyedrops manufactured by the company and valid period is until Feb. 8, 2023\nSource text in Chinese: goo.gl/WJjpzU\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-02-13T16:52:00.000+02:00",
    "crawled": "2018-02-14T12:34:23.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "hangzhou",
        "tianmushan",
        "pharmaceutical",
        "enterprise",
        "co",
        "ltd",
        "say",
        "received",
        "good",
        "manufacture",
        "practice",
        "gmp",
        "certificate",
        "zhejiang",
        "food",
        "drug",
        "administration",
        "certificate",
        "issued",
        "eyedrop",
        "manufactured",
        "company",
        "valid",
        "period",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}